Supply Chain

Emergency departments across the United States are facing a shortage of intravenous nitroglycerin, a drug commonly used to treat heart complications.

Mentor, Ohio-based Steris Corp. has announced a definitive agreement to acquire Birmingham, Ala.-based Integrated Medical Systems International for $165 million, plus $10 million to purchase real estate.

GlaxoSmithKline has stopped phase III trials on its MAGE-A3 cancer immunotherapeutic in non-small cell lung cancer patients, saying it may be impossible to identify a sub-population of NSCL patients who may benefit from the treatment.

Sovaldi, a newly approved drug to treat Hepatitis C, could see between $5 billion and $9 billion in sales during its first year on the market, one of the largest sales for a new drug's first year, according to a…

The U.S. Food and Drug Administration has given approval to Indianapolis-based Roche Diagnostics to market its Hepatitis B test kit.

Deerfield, Ill.-based Baxter has announced plans to create two separate and independent global healthcare companies.

The U.S. Food and Drug Administration has approved Alprolix, Coagulation Factor IX, Fc Fusion Protein as a treatment option for patients with Hemophilia B.

Lake Zurich, Ill.-based Fresenius Kabi will temporarily distribute normal saline imported from its Norway manufacturing facility to help ease the national saline shortage, according to a U.S. Food and Drug Administration news release.

Intravenous nitroglycerin, a drug often found in emergency rooms as a go-to treatment for heart complications, is running short on supply, according to a Medscape report.

The global ophthalmology device market is expected to reach $9.47 billion by 2018, growing at a compound annual growth rate of 6.8 percent, according to a Markets and Markets news release.